Send Your Enquiry
About Dr. Deborah Mukherji
- Dr. Deborah Mukherji is a Medical Oncologist who has over 22 years of experience.
- She specialises in treating breast cancer, cervical cancer, lung cancer, gastrointestinal cancer, as well as genitourinary and prostate cancer.
- Dr. Deborah did her MBBS from Guy’s and St. Thomas’ NHS Foundation Trust, University of London, in 2002 and Bachelor’s of Science in Cancer Genetics from Kings College London, UK.
- She pursued a fellowship of the Royal College of Physicians (FRCP), UK, in 2016 and a Certificate of Completion Specialist Training (CCST) in Medical Oncology in London, UK.
- Dr. Deborah is a UK board-certified oncologist who also did a Postgraduate Diploma in Oncology from the Institute of Cancer Research in 2011
- Afterwards, she completed a Global Clinical Scholars Research Training Program at the Harvard Medical School in 2015.
- Dr. Deborah was honoured with the Women in Oncology Award MENA by the Emirates Oncology Society in 2021.
- She has authored more than 130 peer-reviewed publications in international journals and is on the editorial board of renowned journals, including Cancer Research Journal, Cancer Research Communications, etc.
- Dr. Deborah is associated with many important organisations, such as the European Society for Medical Oncology, Advanced Prostate Cancer Consensus Conference, ESMO World Congress on Gastrointestinal Cancer, American Society of Clinical Oncology, etc.
Location
Graduation, Kings College London, UK- MBBS, Guy’s and St. Thomas’ NHS Foundation Trust, University of London(2002)
- Diploma, The Institute of Cancer Research(2011)
- FRCP(2016)
- Women in Oncology Award MENA by the Emirates Oncology Society in 2021
- Associate Professor, American University of Beirut(2015)
- Royal Marsden Hospital, London
Papers Published
- Yusuf A, Sarfati D, Booth CM, Pramesh CS, Lombe D, Aggarwal A, Bhoo-Pathy N, Tsunoda A, Vanderpuye V, Kutluk T, Sullivan A, Mukherji D, Mutebi M, van Hemelrijck M, Sullivan R; COVID-19 and Cancer Global Taskforce. Cancer and COVID-19 vaccines: a complex global picture. Lancet Oncol. 2021 Jun;22(6):749-751. doi: 10.1016/S1470-2045(21)00244-8. Epub 2021 Apr 27. PMID: 33930324, PMCID: PMC8078890
+ Read More- Show Less
- Wells JC, Sharma S, Del Paggio JC, Hopman WM, Gyawali B, Mukherji D, Hammad N, Pramesh CS, Aggarwal A, Sullivan R, Booth CM. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries. JAMA Oncol. 2021 Mar 1;7(3):379-385. doi: 10.1001/jamaoncol.2020.7478. PMID: 33507236, PMCID: PMC7844695
- Shamseddine A, Zeidan YH, El Husseini Z, Kreidieh M, Al Darazi M, Turfa R, Kattan J, Khalifeh I, Mukherji D, Temraz S, Alqasem K, Amarin R, Al Awabdeh T, Deeba S, Jamali F, Mohamad I, Elkhaldi M, Daoud F, Al Masri M, Dabous A, Hushki A, Jaber O, et al. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma. Radiat Oncol. 2020 Oct 7;15(1):233. doi: 10.1186/s13014-020-01673-6. PMID: 33028346, PMCID: PMC7542723
- Mukherji D, Youssef B, Dagher C, El-Hajj A, Nasr R, Geara F, Rabah D, Al Dousari S, Said R, Ashou R, Wazzan W, Jabbour M, Farha G, Al Hamdani N, Al Hallaq Y, Ghazal H, Dbouk H, Bachir B, El Khoury C, Sakr G, Hussain HK, Sayyid K, et al. Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations. World J Urol. 2020 Mar;38(3):681-693. doi: 10.1007/s00345-019-02872-x. PMID: 31297628, PMCID: PMC7064460
- Mukherji D, Omlin A, Pezaro C. Living Longer and Better with Advanced Prostate Cancer. Eur Urol. 2020 Sep;78(3):358-359. doi: 10.1016/j.eururo.2020.05.020. Epub 2020 Jun 15. PMID: 32553618
- Cheaito K, Bahmad HF, Jalloul H, Hadadeh O, Msheik H, El-Hajj A, Mukherji D, Al-Sayegh M, Abou-Kheir W. Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids. Front Cell Dev Biol. 2020 Oct 29;8:571677. doi: 10.3389/fcell.2020.571677. PMID: 33195205, PMCID: PMC7658326
- Abou-Kheir W, Mukherji D, Hadadeh O, Saleh E, Bahmad HF, Kanso M, Khalifeh M, Shamseddine A, Tamraz S, Jaafar R, Dagher C, Khalifeh I, Faraj W. CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding microenvironment. Heliyon. 2020 May 3;6(5):e03842. doi: 10.1016/j.heliyon.2020.e03842. PMID:32395647, PMCID: PMC7205742
- Abdul-Sater Z, Menassa M, El Achi N, Abdul-Khalek RA, Abu-Sittah G, Mukherji D. Strengthening capacity for cancer research in conflict settings: key informant insights from the Middle East. Ecancermedicalscience. 2020 Dec 10;14:1153. doi: 10.3332/ecancer.2020.1153. PMID: 33574898,PMCID: PMC7864685
- Abdul-Sater Z, Shamseddine A, Taher A, Fouad F, Abu-Sitta G, Fadhil I, Saab R, Sullivan R, Adib SM, Saleh S, Mukherji D; ICRIM. Cancer Registration in the Middle East, North Africa, and Turkey: Scope and Challenges. JCO Glob Oncol. 2021 Jul;7:1101-1109. doi: 10.1200/GO.21.00065. PMID: 34236931
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Medical Oncologist In Dubai
Chat
FAQ's About Dr. Deborah Mukherji
Where does Dr. Deborah Mukherji practice?
Dr. Deborah Mukherji practices at CMC Dubai
What is the specialty of Dr. Deborah Mukherji?
Dr. Deborah Mukherji specialty is Medical Oncologist
What is the experience of Dr. Deborah Mukherji?
Dr. Deborah Mukherji is Medical Oncologist with 22 years of experience.
Chat